The estimated Net Worth of Phil Skolnick is at least 1.45 百万$ dollars as of 27 January 2023. Dr Skolnick owns over 480 units of Opiant Pharmaceuticals Inc stock worth over 444,966$ and over the last 6 years he sold OPNT stock worth over 316,160$. In addition, he makes 685,784$ as Chief Scientific Officer at Opiant Pharmaceuticals Inc.
Dr has made over 23 trades of the Opiant Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 480 units of OPNT stock worth 9,725$ on 27 January 2023.
The largest trade he's ever made was exercising 10,000 units of Opiant Pharmaceuticals Inc stock on 2 January 2020 worth over 90,000$. On average, Dr trades about 5,703 units every 57 days since 2018. As of 27 January 2023 he still owns at least 21,548 units of Opiant Pharmaceuticals Inc stock.
You can see the complete history of Dr Skolnick stock trades at the bottom of the page.
Dr. Phil Skolnick D.Sc. (hon), Ph.D. is the Chief Scientific Officer at Opiant Pharmaceuticals Inc.
As the Chief Scientific Officer of Opiant Pharmaceuticals Inc, the total compensation of Dr D at Opiant Pharmaceuticals Inc is 685,784$. There are 3 executives at Opiant Pharmaceuticals Inc getting paid more, with Roger Crystal having the highest compensation of 5,413,730$.
Dr D is 74, he's been the Chief Scientific Officer of Opiant Pharmaceuticals Inc since . There are 1 older and 8 younger executives at Opiant Pharmaceuticals Inc. The oldest executive at Opiant Pharmaceuticals Inc is Michael Sinclair, 77, who is the Executive Chairman of the Board.
Phil's mailing address filed with the SEC is C/O OPIANT PHARMACEUTICALS, INC., 233 WILSHIRE BLVD., SUITE 400, SANTA MONICA, CA, 90401.
Over the last 21 years, insiders at Opiant Pharmaceuticals Inc have traded over 16,027,532$ worth of Opiant Pharmaceuticals Inc stock and bought 199,545 units worth 2,080,156$ . The most active insiders traders include Craig A Collard、Marc A Cohen、Alain J Cohen. On average, Opiant Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of 159,046$. The most recent stock trade was executed by Roger Crystal on 27 January 2023, trading 1,358 units of OPNT stock currently worth 27,513$.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Opiant Pharmaceuticals Inc executives and other stock owners filed with the SEC include: